Advances in Oncology, 2023, Volume 3-1 (Hardcover)

Advances in Oncology reviews the year's most important findings and updates within the field in order to provide practicing oncologists with the current clinical information they need to improve patient outcomes. A distinguished editorial board, led by Dr. Leonidas C. Platanias, identifies key areas of major progress and controversy and invites preeminent specialists to contribute original articles devoted to these topics. These insightful overviews in oncology inform and enhance clinical practice by bringing concepts to a clinical level and exploring their everyday impact on patient care. Contains 25 articles on such topics as de-escalation therapy for HPV-associated oropharyngeal cancer; management of in-transit metastatic melanoma; rare gynecologic tumors; pediatric lymphoma: advances with an eye on disparities; the microbiome and CNS tumors; adjuvant therapy for patients with high-risk urothelial cancer following surgery; targeting the RAS gene for treatment of GI cancers; and more. Provides in-depth, clinical reviews in oncology, providing actionable insights for clinical practice. Presents the latest information in the field under the leadership of an experienced editorial team. Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews.

General

Imprint:	Churchill Livingstone
Country of origin:	United Kingdom
Series:	Advances
Release date:	May 2023
First published:	2023
Editors:	Leonidas C Platanias
Dimensions:	235 x 191mm (L x W)
Format:	Hardcover
Pages:	240
ISBN-13:	978-0-443-18270-9
Categories:	Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General Promotions
LSN:	0-443-18270-1
Barcode:	9780443182709

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!